These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38306124)

  • 1. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
    Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
    J Drugs Dermatol; 2024 Feb; 23(2):54-60. PubMed ID: 38306124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
    Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
    J Drugs Dermatol; 2023 Dec; 22(12):7691. PubMed ID: 38051842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel.
    Burshtein J; Zakria D; Shah M; Berman B; Desai SR; Farberg AS; Goldenberg G; Glick B; Nestor M; Nouri K; Rosen T; Lebwohl M; Rigel D
    J Drugs Dermatol; 2024 Sep; 23(9):774-781. PubMed ID: 39231082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
    Rebeca T; Giselle P; Litchman GH; Rigel DS
    J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
    Burshtein J; Shah M; Zakria D; Lockshin B; Crowley J; Merola JF; Gordon K; Shahriari M; Korman NJ; Chovatiya R; Kalb R; Lebwohl M
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):323-339. PubMed ID: 38340237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
    Burshtein J; Shah M; Zakria D; Armstrong AW; Golant AK; Gottlieb AB; Weinberg JM; Kircik L; Han G; Langley RG; Neimann AL; Lebwohl M
    J Drugs Dermatol; 2024 Aug; 23(8):592-599. PubMed ID: 39093660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
    Hooper PB; Farberg AS; Fitzgerald AL; Siegel JJ; Rackley BB; Prasai A; Kurley SJ; Goldberg MS; Litchman GH
    Cancer Invest; 2022 Nov; 40(10):911-922. PubMed ID: 36073945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma Management.
    Arron ST; Blalock TW; Guenther JM; Hyams DM; Ibrahim SF; Koyfman SA; Wysong A
    J Drugs Dermatol; 2021 Jun; 20(6):5s-s11. PubMed ID: 34076385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
    Litchman GH; Fitzgerald AL; Kurley SJ; Cook RW; Rigel DS
    Curr Med Res Opin; 2020 Aug; 36(8):1295-1300. PubMed ID: 32372702
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrating 40-GEP Testing to Improve Clinical Recommendations for Adjuvant Radiation for Cutaneous Squamous Cell Carcinoma: Multidisciplinary Consensus Guidelines.
    Gopal R; Marquardt M; Singh G; Tolkachjov SN; Arron ST
    J Clin Aesthet Dermatol; 2024 Mar; 17(3 Suppl 2):S3-S8. PubMed ID: 38495846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
    Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
    J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.
    Farberg AS; Hall MA; Douglas L; Covington KR; Kurley SJ; Cook RW; Dinehart SM
    Curr Med Res Opin; 2020 Aug; 36(8):1301-1307. PubMed ID: 32351136
    [No Abstract]   [Full Text] [Related]  

  • 13. Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.
    Farberg AS; Marson JW; Glazer A; Litchman GH; Svoboda R; Winkelmann RR; Brownstone N; Rigel DS;
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):807-823. PubMed ID: 35353350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
    Kashani-Sabet M; Leachman SA; Stein JA; Arbiser JL; Berry EG; Celebi JT; Curiel-Lewandrowski C; Ferris LK; Grant-Kels JM; Grossman D; Kulkarni RP; Marchetti MA; Nelson KC; Polsky D; Seiverling EV; Swetter SM; Tsao H; Verdieck-Devlaeminck A; Wei ML; Bar A; Bartlett EK; Bolognia JL; Bowles TL; Cha KB; Chu EY; Hartman RI; Hawryluk EB; Jampel RM; Karapetyan L; Kheterpal M; Lawson DH; Leming PD; Liebman TN; Ming ME; Sahni D; Savory SA; Shaikh SS; Sober AJ; Sondak VK; Spaccarelli N; Usatine RP; Venna S; Kirkwood JM
    JAMA Dermatol; 2023 May; 159(5):545-553. PubMed ID: 36920356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm.
    Singh G; Tolkachjov SN; Farberg AS
    Clin Cosmet Investig Dermatol; 2023; 16():925-935. PubMed ID: 37051586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
    Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
    JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
    Ibrahim SF; Kasprzak JM; Hall MA; Fitzgerald AL; Siegel JJ; Kurley SJ; Covington KR; Goldberg MS; Farberg AS; Trotter SC; Reed K; Brodland DG; Koyfman SA; Somani AK; Arron ST; Wysong A
    Future Oncol; 2022 Mar; 18(7):833-847. PubMed ID: 34821148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
    Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
    J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.